GUFICBIO.NSGUFICBIO.NSNSE
Loading
EBITDA Margin Over TimeContracting
Percentile Rank60
3Y CAGR-9.1%
5Y CAGR-3.2%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
-9.1%/yr
vs +8.6%/yr prior
5Y CAGR
-3.2%/yr
Recent deceleration
Acceleration
-17.7pp
Decelerating
Percentile
P60
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM14.93%-11.5%
202516.87%-8.1%
202418.35%-7.6%
202319.87%+4.3%
202219.06%+8.3%
202117.59%+17.6%
202014.96%+4.9%
201914.26%-1.3%
201814.45%+43.0%
201710.11%-